Shandong Sito Bio-technology Co., Ltd. (SHE:300583)

China · Delayed Price · Currency is CNY

11.26

-0.14 (-1.23%)

Nov 6, 2026, 10:15 AM CST

Market Cap	2.14B -27.2%
Revenue (ttm)	1.14B +19.2%
Net Income	29.09M
EPS	0.15
Shares Out	189.70M
PE Ratio	73.14
Forward PE	n/a
Dividend	0.02 (0.13%)
Ex-Dividend Date	Jul 14, 2026

Volume	1,566,552
Open	11.51
Previous Close	11.40
Day's Range	11.07 - 11.51
52-Week Range	10.59 - 16.27
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:300583

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9α-hydroxyandrost, 17α-hydroxyprogesterone, 17α-hydroxy progesterone derivatives, anecort acetate, bis-decyl alcohol (BA), neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, 16β and 16α methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. It also provides APIs for animal he... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 990

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300583

Full Company Profile

Financial Performance

In 2025, SHE:300583's revenue was 1.02 billion, an increase of 4.77% compared to the previous year's 970.60 million. Losses were -73.15 million, -17.60% less than in 2024.

Financial Statements